10-K Decoder · All companies

Corvus Pharmaceuticals, Inc.

CRVS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$43.0M−$27.6M−56.0%
Net income−$15.3M−$62.3M+75.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$21.4M−$10.6M−102%
Net income−$20.3M−$10.2M−99.0%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Corvus's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Corvus profitable in FY2025?
No: net income was −$15.3M and operating income −$43.0M in FY2025.
What was Corvus's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.